KINGSTON, R.I. (AP) — Javonte Brown had 17 points in Rhode Island's 91-53 victory against Charleston (SC) on Sunday. Brown added seven rebounds and four blocks for the Rams (5-0). Jamarques Lawrence shot 6 for 11, including 4 for 8 from beyond the arc to add 16 points. Sebastian Thomas shot 5 for 10 (3 for 6 from 3-point range) and 2 of 4 from the free-throw line to finish with 15 points. AJ Smith finished with 10 points for the Cougars (4-2). Derrin Boyd added nine points and four assists for Charleston (SC). Deywilk Tavarez also had nine points. Rhode Island took the lead with 19:31 left in the first half and did not give it up. Brown led his team in scoring with 10 points in the first half to help put them up 45-16 at the break. Rhode Island outscored Charleston (SC) by nine points over the final half, while Lawrence led the way with a team-high eight second-half points. NEXT UP Both teams next play Wednesday. Rhode Island plays Detroit Mercy and Charleston (SC)plays Northern Kentucky at home. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
Opioid Withdrawal Syndrome Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, Therapies, Mechanism of Action, Route of Administration, and Developments | Chiesi Farmaceutici S.p.A., BioXcel Therapeutics, Braeburn Pharmaceuticals, Indivior 11-22-2024 09:25 PM CET | Health & Medicine Press release from: DelveIinsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Opioid Withdrawal Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Opioid Withdrawal Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Opioid Withdrawal Syndrome Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Opioid Withdrawal Syndrome Market. The Opioid Withdrawal Syndrome Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Opioid Withdrawal Syndrome Pipeline Report: https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel Opioid Withdrawal Syndrome treatment therapies with a considerable amount of success over the years. •Opioid Withdrawal Syndrome companies working in the treatment market are Chiesi Farmaceutici S.p.A., BioXcel Therapeutics, Braeburn Pharmaceuticals, Indivior, and others, are developing therapies for the Opioid Withdrawal Syndrome treatment •Emerging Opioid Withdrawal Syndrome therapies in the different phases of clinical trials are- CHF-6563, BXCL501, BRIXADI (buprenorphine), SUBLOCADE (buprenorphine), CAM2038, and others are expected to have a significant impact on the Opioid Withdrawal Syndrome market in the coming years. •In October 2024, ANANDA Scientific Inc., a biopharmaceutical company focused on research, today announced the initiation of a clinical trial to evaluate NantheiaTM ATL5. This investigational drug combines cannabidol with ANANDA's proprietary delivery technology and is co-administered with delta-9-tetrahydrocannabinol (THC). The trial aims to assess its potential effectiveness in treating co-occurring opioid use disorder (OUD) and chronic pain. (Clinical Trials.gov Identifier: NCT06544291) Opioid Withdrawal Syndrome Overview Opioid Withdrawal Syndrome is a condition that occurs when individuals who are dependent on opioids abruptly reduce or stop their use. It results from the body's adaptation to prolonged opioid use, leading to physical dependence. Symptoms of withdrawal can range from mild to severe and typically include anxiety, agitation, muscle aches, sweating, nausea, vomiting, diarrhea, and insomnia. While the syndrome itself is not life-threatening, it can be extremely uncomfortable and may lead to relapse if not managed properly. Treatment often includes supportive care, medications like buprenorphine or methadone, and behavioral therapy to aid recovery. Get a Free Sample PDF Report to know more about Opioid Withdrawal Syndrome Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Emerging Opioid Withdrawal Syndrome Drugs Under Different Phases of Clinical Development Include: •CHF-6563: Chiesi Farmaceutici S.p.A. •BXCL501: BioXcel Therapeutics •BRIXADI (buprenorphine): Braeburn Pharmaceuticals •SUBLOCADE (buprenorphine): Indivior •CAM2038: Braeburn Pharmaceuticals Opioid Withdrawal Syndrome Route of Administration Opioid Withdrawal Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical Opioid Withdrawal Syndrome Molecule Type Opioid Withdrawal Syndrome Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy Opioid Withdrawal Syndrome Pipeline Therapeutics Assessment •Opioid Withdrawal Syndrome Assessment by Product Type •Opioid Withdrawal Syndrome By Stage and Product Type •Opioid Withdrawal Syndrome Assessment by Route of Administration •Opioid Withdrawal Syndrome By Stage and Route of Administration •Opioid Withdrawal Syndrome Assessment by Molecule Type •Opioid Withdrawal Syndrome by Stage and Molecule Type DelveInsight's Opioid Withdrawal Syndrome Report covers around 4+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further Opioid Withdrawal Syndrome product details are provided in the report. Download the Opioid Withdrawal Syndrome pipeline report to learn more about the emerging Opioid Withdrawal Syndrome therapies at: https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the Opioid Withdrawal Syndrome Therapeutics Market include: Key companies developing therapies for Opioid Withdrawal Syndrome are - Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., Trevena, Aphios, Kyowa kirin, Gamida-Cell, BioDelivery Sciences International, Inc., and others. Opioid Withdrawal Syndrome Pipeline Analysis: The Opioid Withdrawal Syndrome pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of Opioid Withdrawal Syndrome with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Opioid Withdrawal Syndrome Treatment. •Opioid Withdrawal Syndrome key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •Opioid Withdrawal Syndrome Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Opioid Withdrawal Syndrome market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Opioid Withdrawal Syndrome drugs and therapies- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Opioid Withdrawal Syndrome Pipeline Market Drivers •Rising Prevalence of Opioid Addiction, Awareness Programs, Advancements in Treatments, Supportive Regulations, Integration of Telemedicine, are some of the important factors that are fueling the Opioid Withdrawal Syndrome Market. Opioid Withdrawal Syndrome Pipeline Market Barriers •However, Stigma Associated with Addiction, High Treatment Costs, Limited Access in Rural Areas, Regulatory Challenges, and other factors are creating obstacles in the Opioid Withdrawal Syndrome Market growth. Scope of Opioid Withdrawal Syndrome Pipeline Drug Insight •Coverage: Global •Key Opioid Withdrawal Syndrome Companies: Chiesi Farmaceutici S.p.A., BioXcel Therapeutics, Braeburn Pharmaceuticals, Indivior, and others •Key Opioid Withdrawal Syndrome Therapies: CHF-6563, BXCL501, BRIXADI (buprenorphine), SUBLOCADE (buprenorphine), CAM2038, and others •Opioid Withdrawal Syndrome Therapeutic Assessment: Opioid Withdrawal Syndrome current marketed and Opioid Withdrawal Syndrome emerging therapies •Opioid Withdrawal Syndrome Market Dynamics: Opioid Withdrawal Syndrome market drivers and Opioid Withdrawal Syndrome market barriers Request for Sample PDF Report for Opioid Withdrawal Syndrome Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. Opioid Withdrawal Syndrome Report Introduction 2. Opioid Withdrawal Syndrome Executive Summary 3. Opioid Withdrawal Syndrome Overview 4. Opioid Withdrawal Syndrome- Analytical Perspective In-depth Commercial Assessment 5. Opioid Withdrawal Syndrome Pipeline Therapeutics 6. Opioid Withdrawal Syndrome Late Stage Products (Phase II/III) 7. Opioid Withdrawal Syndrome Mid Stage Products (Phase II) 8. Opioid Withdrawal Syndrome Early Stage Products (Phase I) 9. Opioid Withdrawal Syndrome Preclinical Stage Products 10. Opioid Withdrawal Syndrome Therapeutics Assessment 11. Opioid Withdrawal Syndrome Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Opioid Withdrawal Syndrome Key Companies 14. Opioid Withdrawal Syndrome Key Products 15. Opioid Withdrawal Syndrome Unmet Needs 16 . Opioid Withdrawal Syndrome Market Drivers and Barriers 17. Opioid Withdrawal Syndrome Future Perspectives and Conclusion 18. Opioid Withdrawal Syndrome Analyst Views 19. Appendix 20. About DelveInsight Related Reports: Opioid Withdrawal Syndrome Market https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), Opioid Withdrawal Syndrome Epidemiology https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Opioid Withdrawal Syndrome Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Latest Reports: •Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape •Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights •Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market •Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market •Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market •Substance Use Disorder Market: https://www.delveinsight.com/report-store/substance-use-disorder-market Contact Us: Gaurav Bora gbora@delveinsight.com +14699457679 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.
China to work closely with new Govt- Chinese EnvoySHANGHAI (Reuters): China’s Huawei, blacklisted by the U.S., said on Saturday it is targeting 100,000 applications for its Harmony operating system in coming months as it seeks widespread help to achieve self-reliance. The tech giant has more than 15,000 applications based on Harmony that can meet consumers’ basic needs, but the ecosystem requires more personalised and boutique apps, Huawei Chairman Xu Zhijun told a conference on Saturday. “Based on our analysis, for the Harmony ecosystem to be mature in meeting consumer needs, 100,000 apps is the milestone, and that is the key objective over the next six to 12 months,” Xu said in a speech posted on the WeChat messaging app. The ambitious app target highlights the urgency in developing home-grown technologies as China faces elevated tensions with the U.S. in areas ranging from trade to technology as President-elect Donald Trump threatens to be tougher on China. Huawei launched its operating system five years ago after U.S. sanctions cut off support for Google’s Android. The Shenzhen-based company, which sells products ranging from smartphones to laptops, later developed an open-source version of the Harmony system. Due to the U.S. sanctions, “Huawei has been forced to accelerate developing its own operating system,” Xu said. Although much progress has been made, “for any operation system, no matter how advanced it is, it would be of no value if no one uses it.” Xu expressed hope that developers could work hard to enrich app offerings and called on government agencies, state companies and social organizations to use Harmony as their operating system at work. He asked consumers to be tolerant of the system’s immaturity, saying, “The more people use it, the more quickly it will become mature.” Huawei unveiled Harmony in August 2019, three months after Washington placed it under trade restrictions over alleged security concerns. Huawei denies its equipment poses a risk. “No way back leads to victory,” Xu said. “Huawei will unwaveringly invest in developing the Harmony ecosystem, and strive to make the impossible possible.”
No. 11 Tennessee crushes UTEP to enhance CFP chancesJoe Sacco: Younger people give me hope. They do not look at Palestine, Israel the same wayLSU vs. Oklahoma live stream, where to watch, TV channel, kickoff time, odds, spread, prediction, pick
SOMERVILLE, N.J. , Nov. 23, 2024 /PRNewswire/ -- Specified Technologies Inc. has announced their latest Firestop Clash Management (FCM) and Firestop Locator (FSL) releases. FCM automates the process of locating and assigning firestop solutions to conditions within Autodesk ® Revit ® , enabling firestop novices to find firestop solutions like a firestop expert. In this latest release, STI has further expanded the capabilities of FCM by integrating it with their firestop documentation and compliance tool, Firestop Locator (FSL). FSL enables contractors and facilities' teams to document the status, location, and products used for any and all fire life safety services across a building. In the latest update for FSL, teams can now create custom items to track any service on their project beyond the base six (Penetration, Joint, Extinguisher, Door, Damper, and Barrier). Teams can also modify the base six items to include project specific inspection and maintenance requirements and any other details that they would like to be tracked. With this new integration, decisions made during the design phase of a building using FCM are seamlessly passed into FSL during the construction phase, giving implementation teams a jump start on work to be done. This integration also improves data integrity and eliminates the guesswork in the field of determining what firestop systems and products are to be used where. "We're proud of the latest releases of FCM and FSL and look forward to continuing to support the fire life safety community," says Justin Pine, Sr. Manager of Software & Services. Specified Technologies Inc. promotes life and building safety by developing innovative fire protection systems and accompanying digital tools that help stop the spread of fire, smoke, and hot gases. Our SpecSeal® and EZ Path® product lines are engineered for easy installation and deliver powerful performance, often resulting in lower installed costs. Since firestopping is our only business, we concentrate all our resources on providing the highest quality, fully tested, innovative firestopping solutions. Contact: Jess Bern ; jbern@stifirestop.com View original content to download multimedia: https://www.prnewswire.com/news-releases/specified-technologies-inc-unveils-firestop-clash-management-and-locator-updates-302314629.html SOURCE Specified Technologies, Inc.
From the Snakepit to Switzerland: the story of NSW's oldest basketballerSix face trial in Paris for blackmailing Paul Pogba
'We've been through an incredible transition' - O'Neil 'won't give up'Ebonkoli 0-0 0-0 0, Diallo 1-1 0-0 2, Grady 4-7 5-9 16, Petty 7-15 2-4 18, Faas 3-7 0-2 7, Kopp 4-11 9-10 20, Ijeh 0-0 0-0 0, Nyeri 0-3 1-2 1, Hall 0-1 0-0 0, Ammons 0-0 0-0 0, Gob 0-0 1-2 1. Totals 19-45 18-29 65. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Repairs and street lighting planned for city bridge amid safety concernsFirst Trust Nasdaq Cybersecurity ETF (NASDAQ:CIBR) Position Boosted by Caprock Group LLC
Phillips-based school district agrees on how to spend remaining nutrition fundsSOMERVILLE, N.J. , Nov. 23, 2024 /PRNewswire/ -- Specified Technologies Inc. has announced their latest Firestop Clash Management (FCM) and Firestop Locator (FSL) releases. FCM automates the process of locating and assigning firestop solutions to conditions within Autodesk ® Revit ® , enabling firestop novices to find firestop solutions like a firestop expert. In this latest release, STI has further expanded the capabilities of FCM by integrating it with their firestop documentation and compliance tool, Firestop Locator (FSL). FSL enables contractors and facilities' teams to document the status, location, and products used for any and all fire life safety services across a building. In the latest update for FSL, teams can now create custom items to track any service on their project beyond the base six (Penetration, Joint, Extinguisher, Door, Damper, and Barrier). Teams can also modify the base six items to include project specific inspection and maintenance requirements and any other details that they would like to be tracked. With this new integration, decisions made during the design phase of a building using FCM are seamlessly passed into FSL during the construction phase, giving implementation teams a jump start on work to be done. This integration also improves data integrity and eliminates the guesswork in the field of determining what firestop systems and products are to be used where. "We're proud of the latest releases of FCM and FSL and look forward to continuing to support the fire life safety community," says Justin Pine, Sr. Manager of Software & Services. Specified Technologies Inc. promotes life and building safety by developing innovative fire protection systems and accompanying digital tools that help stop the spread of fire, smoke, and hot gases. Our SpecSeal® and EZ Path® product lines are engineered for easy installation and deliver powerful performance, often resulting in lower installed costs. Since firestopping is our only business, we concentrate all our resources on providing the highest quality, fully tested, innovative firestopping solutions. Contact: Jess Bern ; jbern@stifirestop.com View original content to download multimedia: https://www.prnewswire.com/news-releases/specified-technologies-inc-unveils-firestop-clash-management-and-locator-updates-302314629.html SOURCE Specified Technologies, Inc.Cowboys G Zack Martin, CB Trevon Diggs out vs. Commanders
Founder, Managing Director of Resus Energy, Kishan Nanayakkara of Sri Lanka, was recognized at the 7th annual Asia Pacific ‘50 Leading Lights: Kindness in Leadership campaign’ that was released on the recent World Kindness Day. “As we celebrate the seventh year of our 50 Leading Lights: Kindness in Leadership campaign, it’s evident that kindness is much more than a feel-good gesture – it’s a strategic advantage. Both successful leaders and leading academics consistently affirm that kindness enhances wellbeing, fuels innovation, and drives productivity. It is, therefore, a great honour to announce the 2024 APAC Leading Lights list, in association with Asia Square. By leading with kindness, these remarkable men and women transform workplaces into thriving ecosystems where both people and businesses flourish. They are an inspiration to us all”, said Pinky Lilani, CBE DL, Founder, Kindness & Leadership: 50 Leading Lights. Incorporated in 2003, Resus Energy is an award-winning company having won multiple awards across numerous spheres for its work and governance and was amongst the first bracket of Colombo Stock Exchange (CSE) listed companies to adopt Global Reporting Initiative (GRI). Resus Energy’s initial foray into the power sector was through a joint development of a 100MW thermal power plant. In 2007, Resus began developing its first renewable energy project and became a pureplay renewable energy company in 2015. An equal opportunity employer, Resus operates in a strong ‘Environmental, Social and Governance’ system, built around international best practices with ‘caring for people and the planet’ as its ethos, and has been listed on the CSE since 2009. Currently Resus operates 8 small hydropower and 2 ground mounted solar PV stations across five districts in Sri Lanka and dispatches over 70GWh annually to the national grid. Its third solar PV station is currently under construction. Most of Resus’ power stations are in extreme-rural hamlets. Apart from generating clean energy, Resus plays a pivotal role in protecting the natural environment, uplifting livelihoods of families, providing employment to villagers, including women in the surroundings of its power stations.
Sri Lanka Tourism should woo more tourists via marketing campaigns in untapped source markets, said the Minister of Foreign Affairs and Tourism, Vijitha Herath. He was speaking at the 59th Annual General Meeting of The Hotels Association of Sri Lanka (THASL). He said that there are many countries that fall into this category and promotions and road shows should be directed to these areas. He said that more Research and Development should be conducted to find new methods to attract tourists from non tapped markets which will help Sri Lanka to upgrade from a seasonal to a ’year round’ destination. The Minister said that the steps should be taken to increase ‘per spend a day’ by tourists and also make them stay longer. “We wish to make tourism the top forex earner for the country ensuring that its economic benefits also trickle down to the rural areas as well, creating more employment.” Central Bank Governor Dr. Nandalal Weerasinghe said that the tourism stakeholders can look forward to better times as the country’s economic landscape is improving fast and will reach ‘economic normalcy’ next year. “Political stability with a new president backed by a very strong Government will help achieve long-term sustainable economic growth.” Recalling the recent past he said that Sri Lanka was sans both economic and political stability. “However today the country is in a much more stable position on both fronts,.” Dr. Weerasinghe stressed that the new government recognizes tourism as a cornerstone of Sri Lanka’s economic revival and it is committed to positioning Sri Lanka as a top sustainable tourism destination in the world. “This is not only a vital element for short-term solutions to our financial challenges but also a key to long-term sustainable growth.” The president elect Shanthi Kumara said that there was no proper marketing campaign done for more than a decade and this is an urgent need for the sector. He also thanked the ITC hotel for sponsoring and hosting the event. Sri Lanka Tourism Chairman Buddhika Hewawasam said that they are set to unveil a unified national brand in January instead of going ahead with campaign taglines, aiming to redefine the country’s global tourism appeal. “We are targeting over 3 million arrivals and over USD 5 billion revenue for 2025 and hope to further increase these two figures by 2023.”Lucknow: Months after the ruling BJP’s poor Lok Sabha poll performance in Uttar Pradesh, the saffron party hit the opposition parties out of the park by winning six of the nine Assembly seats in the state where bypolls were held on November 20. Adding to BJP’s emphatic performance, its ally Rashtriya Lok Dal (RLD) clinched Meerapur, the lone seat it contested. The Samajwadi Party (SP) emerged victorious on the remaining two seats — Karhal and Sishamau. According to the Election Commission (EC), the BJP candidates emerged victorious in Kundarki, Ghaziabad, Khair (SC), Phulpur, Katehari and Majhawan assembly constituencies. In Phulpur, BJP’s Deepak Patel bagged 78,289 votes to defeat his nearest rival and SP nominee Md Mujtaba Siddiqui by 11,305 votes. In Ghaziabad, saffron party nominee Sanjeev Sharma polled 96,946 votes to trounce his nearest rival Singh Raj Jatav of the SP by 69,351 votes, while his party colleague Surender Diler emerged victorious in Khair, defeating SP’s Charu Kain by 38,393 votes. BJP’s Suchismita Maurya, who bagged 77,737 votes, defeated her nearest rival Jyoti Bind of the SP by 4,922 votes in Majhawan, while Dharmraj Nishad of the BJP won the Katehari seat, beating SP’s Shobhawati Varma by 34,514 votes. In Kundarki, BJP’s Ramveer SIngh made short work of Mohammad Rizwan of the SP, winning by 1,44,791 votes. SP’s Tej Pratap Yadav secured 1,04,304 votes to pip BJP’s Anujesh Pratap Singh by 14,725 votes in Karhal. The seat fell vacant after SP chief Akhilesh Yadav got elected to the Lok Sabha from Kannauj earlier this year. Tej Pratap’s party colleague Naseem Solanki defeated BJP’s Suresh Awasthi by 8,564 votes in Sishamau where Bahujan Samaj Party’s (BSP) Virendra Kumar finished a distant third with 1,410 votes. The bypoll in Sishamau was necessitated after three-time sitting SP MLA Irfan Solanki, the husband of Naseem Solanki, was disqualified following his conviction in a criminal case. In Meerapur, RLD’s Mithilesh Pal bagged 84,304 votes to defeat her nearest rival Sumbul Rana of the SP by 30,796 votes. In the 2022 Assembly elections, the BJP won Phulpur, Ghaziabad, Majhawan and Khair, while the SP emerged victorious in Sishamau, Katehari, Karhal and Kundarki. The RLD, which was an SP ally then, won the Meerapur seat. The Congress stayed away from the bypolls this time after extending support to its INDIA bloc ally SP. The BSP fielded candidates in all nine seats, while the All India Majlis-e-Ittehadul Muslimeen (AIMIM) put up nominees in Ghaziabad, Kundarki and Meerapur. The Aazad Samaj Party (Kanshi Ram) led by Chandrashekhar Aazad was also in the fray in all the seats barring Sishamau. Presently, the BJP has 251 MLAs and the SP 105 in the Uttar Pradesh Assembly. BJP allies Apna Dal (Sonelal), RLD, Suheldev Bharatiya Samaj Party and Nishad Party also have members in the House. The Congress and the Jansatta Dal Loktantrik have two seats each, while the BSP has one MLA in the 403-member Uttar Pradesh Assembly.